<html>
  <head>
    <meta content="text/html; charset=UTF-8" http-equiv="Content-Type">
  </head>
  <body bgcolor="#FFFFFF" text="#000000">
    <p>Hi All, <br>
    </p>
    <p>I'm a new member to this list, but there is a lot of material
      about the harms and concerns behind Closed Generics.  In
      preparation for the meeting later today, I'll post some of it. I'm
      copying Michele Neylon, who was a leader in sharing concerns about
      Closed Generics with the ICANN Community in 2013.</p>
    <p>I don't think there is the time to prepare a robust debate for
      today, but hopefully at your next meeting, you might invite some
      of the names (people &amp; their organizations) that you see in
      these materials into the discussion. There are also Community
      Objections on this issue that you might want to evaluate. <br>
    </p>
    <p>Best regards, Kathy (Kleiman)</p>
    <p>-----------------------------------------------------------------</p>
    <pre><a class="moz-txt-link-freetext" href="https://forum.icann.org/lists/comments-closed-generic-05feb13/msg00174.html">https://forum.icann.org/lists/comments-closed-generic-05feb13/msg00174.html</a>

Dear Sir / Madam

I am submitting these comments on behalf of Blacknight, Ireland's only ICANN 
accredited registrar. 

They do not reflect the formal views of any stakeholder group, but those of our 
company.

We are on the record with respect to our views on this issue, having spoken 
during the public forum at ICANN Toronto 
(<a rel="nofollow" href="http://toronto45.icann.org/node/34215">http://toronto45.icann.org/node/34215</a>) and having sent several letters to 
ICANN's board, which were co-signed by a broad cross-section of the ICANN 
Community:

<a rel="nofollow" href="http://newgtlds.icann.org/en/program-status/correspondence/neylon-et-al-to-chehade-et-al-24sep12-en.pdf">http://newgtlds.icann.org/en/program-status/correspondence/neylon-et-al-to-chehade-et-al-24sep12-en.pdf</a>

<a rel="nofollow" href="http://newgtlds.icann.org/en/program-status/correspondence/neylon-et-al-to-chalaby-et-al-22jan13-en.pdf">http://newgtlds.icann.org/en/program-status/correspondence/neylon-et-al-to-chalaby-et-al-22jan13-en.pdf</a>


Rather than rehash our previous arguments I would prefer to simply state that 
they are unchanged.

I've summarised some of the issues we see with them here:

<a rel="nofollow" href="http://www.internetnews.me/2013/02/23/5-reasons-why-closed-generic-new-gtlds-should-be-opposed/">http://www.internetnews.me/2013/02/23/5-reasons-why-closed-generic-new-gtlds-should-be-opposed/</a>

It is also worth noting that our views are shared by some very large brands who 
have taken the time to submit very rational comments on this topic.

But more importantly both consumer and trade organisations representing large 
numbers of internet users and businesses have too.

Regards

Michele


Mr Michele Neylon
Blacknight Solutions ♞
Hosting &amp; Domains
ICANN Accredited Registrar
<a rel="nofollow" href="http://www.blacknight.co">http://www.blacknight.co</a>
<a rel="nofollow" href="http://blog.blacknight.com/">http://blog.blacknight.com/</a>
Intl. +353 (0) 59  9183072
US: 213-233-1612 
Locall: 1850 929 929
Facebook: <a rel="nofollow" href="http://fb.me/blacknight">http://fb.me/blacknight</a>
Twitter: <a rel="nofollow" href="http://twitter.com/mneylon">http://twitter.com/mneylon</a>
-------------------------------
Blacknight Internet Solutions Ltd, Unit 12A,Barrowside Business Park,Sleaty
Road,Graiguecullen,Carlow,Ireland  Company No.: 370845</pre>
    <br>
    <div class="moz-cite-prefix">On 4/12/2017 4:45 AM, Michael Flemming
      wrote:<br>
    </div>
    <blockquote
cite="mid:CAAE6pKFb3emd2rTgvU0p0ZzpXNkORbTgqbuaLzSeZVLKp4c99w@mail.gmail.com"
      type="cite">
      <div dir="ltr">Dear All,
        <div><br>
        </div>
        <div>Please find the material that we will be referring to in
          order to address potential harms of Closed Generics.</div>
        <div><br>
        </div>
        <div>Kind regards,</div>
        <div><br>
        </div>
        <div>Michael Flemming</div>
        <div><br>
          <div class="gmail_extra">
            <br>
            <div class="gmail_quote">On Mon, Apr 10, 2017 at 6:28 PM,
              Michael Flemming <span dir="ltr">&lt;<a
                  moz-do-not-send="true"
                  href="mailto:flemming@brightsconsulting.com"
                  target="_blank">flemming@brightsconsulting.com</a>&gt;</span>
              wrote:<br>
              <blockquote class="gmail_quote" style="margin:0 0 0
                .8ex;border-left:1px #ccc solid;padding-left:1ex">
                <div dir="ltr"><span style="font-size:12.8px">Dear All,</span>
                  <div style="font-size:12.8px"><br>
                  </div>
                  <div style="font-size:12.8px">This week on 13 April
                    2017 at 21 UTC we will be once again discussing
                    Closed Generics. As of our last meeting, we went
                    through the Pros and Cons of Closed Generics by
                    looking at the comments made in the Public Comments.
                    We have not reached a consensus on anything at this
                    point, however, we have not had a lot of input for
                    the Cons and potential harm of Closed Generics at
                    the current time. This week we will try to
                    distinguish what potential harm exists if Closed
                    Generics were allowed by analyzing the Public
                    Comments even further. I welcome anyone who would
                    like to assist in this discussion and analysis by
                    joining us this week. Below is the <span
                      class="m_-8575844256750814590m_3745383161031865879gmail-il">agenda</span>.</div>
                  <div style="font-size:12.8px"><br>
                  </div>
                  <div style="font-size:12.8px">
                    <ol>
                      <li style="margin-left:15px"><i>Welcome<br>
                          <br>
                        </i></li>
                      <li style="margin-left:15px"><i>SOI<br>
                          <br>
                        </i></li>
                      <li style="margin-left:15px"><i>Closed Generics</i><br>
                        <br>
                      </li>
                      <li style="margin-left:15px"><i>AOB</i></li>
                    </ol>
                    <div><br>
                    </div>
                    <div>I look forward to speaking with everyone and
                      having an exciting conversation!</div>
                    <div><br>
                    </div>
                    <div>Kind regards,</div>
                    <div><br>
                    </div>
                    <div>Michael Flemming</div>
                  </div>
                </div>
              </blockquote>
            </div>
            <br>
          </div>
        </div>
      </div>
      <br>
      <fieldset class="mimeAttachmentHeader"></fieldset>
      <br>
      <pre wrap="">_______________________________________________
Gnso-newgtld-wg-wt2 mailing list
<a class="moz-txt-link-abbreviated" href="mailto:Gnso-newgtld-wg-wt2@icann.org">Gnso-newgtld-wg-wt2@icann.org</a>
<a class="moz-txt-link-freetext" href="https://mm.icann.org/mailman/listinfo/gnso-newgtld-wg-wt2">https://mm.icann.org/mailman/listinfo/gnso-newgtld-wg-wt2</a></pre>
    </blockquote>
    <br>
  </body>
</html>